Purchases and Sales Made in Q4 2024 in Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN) during Q4 2024. The information is specifically focused on institutions that hold shares of UroGen Pharma Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-92.5K- 78.39% |
$973K - $1.21M
|
25.5K
$393K
|
|
|
Feb 12, 2025
Q4 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-99.1K- 36.49% |
$1.04M - $1.3M
|
173K
$2.66M
|
|
|
Feb 14, 2025
Q4 2024
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-184K- 45.56% |
$1.94M - $2.41M
|
220K
$3.39M
|
|
|
Feb 14, 2025
Q4 2024
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-571K- 75.24% |
$6.01M - $7.49M
|
188K
$2.89M
|
|
|
Feb 14, 2025
Q4 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-808K- 21.62% |
$8.5M - $10.6M
|
2.93M
$45.1M
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-853K- 56.92% |
$8.98M - $11.2M
|
646K
$9.95M
|
|
|
Feb 14, 2025
Q4 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.19M- 78.95% |
$12.5M - $15.6M
|
317K
$4.89M
|
|
|
Feb 14, 2025
Q4 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-1.25M- 80.65% |
$13.2M - $16.4M
|
300K
$4.62M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.41M- 64.83% |
$14.9M - $18.5M
|
767K
$11.8M
|